Health Condition 1: null- Patients undergoing sleep endoscopy for obstructive sleep apnea
Conditions
Interventions
Intervention1: Group D- receives dexmedetomidine for sedation: Dexmedetomidine bolus of 1mcg/kg given over 10 minutes, followed by infusion at 0.5 mcg/ kg/hour -1mcg/kg/hour to achieve the required s
Sponsors
Postgraduate Institute of medical education and research
Eligibility
Inclusion criteria
Inclusion criteria: All ASA I and II patients between the age of 18-60 years scheduled to undergo Drug induced sleep endoscopy
Exclusion criteria
Exclusion criteria: • patients who have undergone previous upper airway surgery for OSA • severe co morbidity (ASA 3 or more) • allergy to dexmedetomidine and propofol • gross mandibular or maxillary deformity
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Degree of airway collapsibility at different levels of sedationTimepoint: compare the degree of airway collapsibility with Propofol and Dexmedetomidine at different levels of sedation by BIS during Drug Induced Sleep Endoscopy | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.cardiopulmonary effects 2. Time to achieve sufficient sedation 3. Haemodynamic response to drugs 4.Side effects and to identify the contributing factors for airway collapsibility.Timepoint: 5 minutes,10 minutes, 15 minutes, 20 minutes, 30 minutes, 40 minutes, 50 minutes, 60 minutes. | — |
Countries
India
Contacts
Public ContactDivya jain
Postgraduate Institute of medical education and research
Outcome results
None listed